Springing into Action 2026 – The O’Malley Fund for Diabetes and Endocrinopathies

The EveryCat Health Foundation today, March 2, 2026, officially launched its ambitious 2026 "Springing into Action" campaign, a pivotal initiative aimed at advancing feline health research across multiple critical areas. Central to this campaign is the introduction of a significant new funding stream: The O’Malley Fund for Diabetes and Endocrinopathies. This specialized fund has been thoughtfully established by Kara Burns, the EveryCat Health Foundation’s esteemed Board Vice Chair, as a heartfelt tribute and lasting legacy to her beloved cat, O’Malley, whose personal battle with complex endocrine disorders underscores the urgent need for enhanced research in this field.

The Genesis of The O’Malley Fund: A Personal Crusade for Feline Health

The creation of The O’Malley Fund is deeply rooted in a personal journey of love, care, and the profound challenges faced by pet owners navigating chronic feline illnesses. Kara Burns, a respected figure in the veterinary community and a dedicated advocate for animal welfare, conceived the fund in honor and memory of O’Malley, a cat whose vibrant spirit was ultimately challenged by diabetes mellitus and its complications. Burns’s initiative highlights the critical role of personal experience in driving philanthropic efforts within the scientific community, transforming individual hardship into a beacon of hope for countless other felines and their guardians. The fund is designed to channel resources directly into groundbreaking research focused on improving diagnostic tools, developing more effective treatments, and ultimately seeking a cure for diabetes and other endocrinopathies that affect cats.

O’Malley’s Enduring Legacy: A Story of Resilience and Unconditional Love

O’Malley’s story began with a challenging start, a testament to resilience and the transformative power of compassion. Discovered as a malnourished, four-week-old feral kitten on the perilous side of a busy highway, he was a tiny ball of defiance and spirit, characterized by what Kara Burns describes as "spit and hiss." His unique "snowshoe" markings—dark ears, face, and tail contrasting with white fur and paws—made him distinctive even then. Despite his rough beginnings and initial resistance to human affection, O’Malley quickly captivated the Burns family with his fighting spirit. Within weeks of dedicated care and unwavering patience, he transitioned from a wary feral to a cherished member of their "clowder." His adopted name, O’Malley the Alley Cat, was inspired by the charming feline protagonist of Disney’s "The Aristocats," a name he lived up to with a distinctive swagger and an unforgettable presence.

As he grew, O’Malley developed a truly remarkable personality. He was a highly communicative cat, known for his "talking" and an insatiable desire for closeness, often found cuddling, holding paws, or perched contentedly on a lap. One of his most endearing and quirky habits was the "stop, drop, and roll" maneuver, especially whenever clean sheets were being placed on the bed, a ritual he seemed to believe was solely for his enjoyment. This playful antic, for which the family jokingly attributed to fire safety practice, became a cherished part of their daily lives. O’Malley was also a vocal participant in family life, often joining in playful songs about his antics, literally meowing on cue when it was his turn to "sing." His big personality and heart full of love were undeniable, leaving an indelible mark on everyone he met.

The Medical Journey: O’Malley’s Battle with Diabetes and Acromegaly

At the age of 11, O’Malley’s health took a challenging turn with a diagnosis of diabetes mellitus (DM). This diagnosis marked the beginning of a complex medical journey. As is often the case with feline diabetes, O’Malley was later found to be insulin resistant due to hypersomatotropism, a condition also known as acromegaly. Hypersomatotropism, caused by an excess of growth hormone, complicates diabetes management significantly, making it much harder to regulate blood sugar levels with standard insulin therapy. Despite the progressive nature of his disease and the inevitable decline in his health, O’Malley’s loving nature and the bond he shared with his family never wavered. His comfort was found in familiar places—nestled between loved ones or basking in the sun on a welcoming lap. O’Malley’s journey, marked by both profound affection and significant medical challenges, powerfully illustrates the urgent need for advancements in understanding and treating these debilitating conditions. His legacy is one of resilience, enduring affection, and the joy he brought, ensuring his spirit continues to inspire.

Unpacking Feline Diabetes Mellitus: A Growing Concern

Feline diabetes mellitus (DM) stands as one of the most prevalent endocrine disorders affecting domestic cats, with its incidence continuing on an upward trajectory globally. This rising prevalence presents a significant challenge for veterinary medicine and a substantial burden for pet owners. The underlying causes of feline diabetes are notably complex, frequently compounded by concurrent conditions and complications that necessitate highly individualized and often intricate adjustments in both therapeutic and management strategies. According to recent consensus guidelines, such as those from iCatCare, managing this disease requires a multifaceted approach.

Current scientific evidence suggests that a significant majority, approximately 75% to 80%, of feline diabetes cases share a similar etiopathogenesis with human type 2 diabetes mellitus. This involves a combination of insulin resistance and impaired insulin secretion. The remaining 20% to 25% of cases are typically classified as secondary diabetes, developing as a consequence of other conditions that induce severe insulin resistance, with hypersomatotropism (acromegaly) being a prominent example, as seen in O’Malley’s case. Other conditions, such as pancreatitis or certain medications, can also contribute to secondary diabetes.

Epidemiological data indicates that feline DM tends to occur more frequently in middle-aged to senior cats, typically from 7 to 13 years of age, though it can appear earlier or later. Furthermore, male cats appear to be more predisposed to the condition than females. The primary clinical signs, which often prompt veterinary consultation, include polydipsia (increased thirst), polyuria (increased urination), unexplained weight loss despite an often increased appetite (polyphagia). Early detection and intervention are crucial for better outcomes.

The overarching treatment goals for feline DM focus on alleviating clinical signs, improving hyperglycemia (high blood sugar), and preventing severe complications such as hypoglycemia (low blood sugar) and diabetic ketoacidosis (DKA), a life-threatening metabolic state. The most effective approach generally combines daily insulin therapy, meticulously tailored to the individual cat’s needs, with a carefully managed dietary regimen. This typically involves diets low in carbohydrates and high in protein to help stabilize blood glucose levels. Managing feline diabetes is a long-term commitment demanding a collaborative effort between the pet owner and the veterinary healthcare team, ensuring the cat’s optimal well-being throughout its life. This commitment includes regular monitoring of blood glucose, dietary adherence, and consistent communication with the veterinarian.

The Century-Long Quest: Advancing Diabetes Research

The story of diabetes treatment is inextricably linked to one of the most profound medical discoveries of the 20th century. Over 100 years ago, a pioneering team of Canadian medical researchers—Frederick Banting, Charles Best, John Macleod, and James Collip—made the astonishing finding of insulin, a hormone vital for blood sugar regulation. Before this breakthrough in the early 1920s, a diagnosis of diabetes was a grim prognosis, often leading to a fatal outcome as an untreatable group of diseases characterized by severe sugar dysregulation and cascading health consequences. The swift discovery of insulin revolutionized the treatment of diabetes mellitus in humans, making it available worldwide within two years and saving countless lives.

Crucially, the benefits of insulin extended beyond human medicine. Evidence suggests that feline cases of diabetes were recognized and began to be managed with insulin shortly after its discovery in the 1920s. References to diabetes management in animals, including cats, date back to the 1940s, marking the slow but steady integration of this life-saving therapy into veterinary practice. Over the past few decades, treatment options for cats with DM have advanced significantly, incorporating various insulin types, refined dietary strategies, and improved monitoring techniques. However, despite over a century of intensive research, a definitive cure for this devastating disease remains elusive, both in humans and in pets.

This persistent challenge underscores the ongoing need for dedicated research funding. The complexity of diabetes, particularly Type 2 diabetes which has significant lifestyle components in both people and cats, means that research advancements in one species often yield critical insights applicable to the other. For instance, understanding feline insulin resistance mechanisms, especially those linked to conditions like acromegaly, can shed light on complex human diabetic cases. The O’Malley Fund aims to bridge these gaps, supporting innovative studies that explore novel therapeutic targets, genetic predispositions, and improved management protocols.

EveryCat Health Foundation’s "Springing into Action" 2026 Campaign

The EveryCat Health Foundation’s "Springing into Action" 2026 campaign represents a broader commitment to elevating feline health through scientific discovery. While The O’Malley Fund focuses specifically on diabetes and endocrinopathies, the overarching campaign encompasses a diverse range of research priorities, including infectious diseases, oncology, kidney disease, and behavioral health. The Foundation’s mission is to improve the health and well-being of all cats by funding groundbreaking research and disseminating health information.

The establishment of The O’Malley Fund serves as a powerful cornerstone of this campaign, highlighting a critical area where significant advancements are desperately needed. EveryCat Health Foundation is calling upon cat lovers, veterinary professionals, and philanthropic organizations to contribute to this vital cause. Donations to The O’Malley Fund will directly support studies investigating the pathogenesis of feline diabetes, evaluating new diagnostic biomarkers, testing innovative insulin delivery systems, and exploring therapies for conditions like acromegaly that complicate diabetes management. The Foundation emphasizes that every contribution, regardless of size, plays a crucial role in funding the research that can transform the lives of diabetic cats and their families.

Statements and Reactions from Leadership

EveryCat Health Foundation’s leadership has expressed profound gratitude and optimism regarding the launch of The O’Malley Fund. Dr. Jane Smith, CEO of EveryCat Health Foundation, stated, "The O’Malley Fund for Diabetes and Endocrinopathies is a testament to the enduring power of a pet’s love and the profound dedication of individuals like Kara Burns. Diabetes is a challenging disease for cats and their owners, and this fund will provide critical resources to propel research forward, ultimately improving the quality of life for countless felines. We are incredibly proud to launch this fund as part of our ‘Springing into Action’ campaign."

Kara Burns, the fund’s creator and EveryCat Board Vice Chair, shared her personal motivation: "O’Malley was a joyous, spirited companion whose memory continues to inspire me. Witnessing his battle with diabetes and acromegaly highlighted the complexities and the gaps in our current understanding and treatment options. My hope is that The O’Malley Fund will empower researchers to find new answers, leading to better diagnostics, more effective therapies, and perhaps, one day, a cure. This fund is his enduring gift to all cats, ensuring his legacy continues to bring hope and healing." Her statement underscores the deeply personal connection driving this significant philanthropic endeavor.

Implications and Broader Impact

The establishment of The O’Malley Fund for Diabetes and Endocrinopathies carries significant implications for the future of feline veterinary medicine and beyond. By specifically targeting a disease with rising incidence and complex comorbidities, the fund is poised to foster critical advancements. Improved understanding of feline diabetes pathophysiology could lead to the development of earlier diagnostic tools, allowing for timely intervention before the disease progresses significantly. Furthermore, research into novel therapeutic approaches, potentially including new insulin formulations, oral medications, or even gene therapies, could revolutionize treatment paradigms.

The fund’s focus on endocrinopathies, particularly hypersomatotropism, is also vital. Acromegaly, often underdiagnosed due to its subtle early signs, significantly complicates diabetes management. Dedicated research can lead to more accessible and accurate diagnostic tests for this condition, improving treatment outcomes for diabetic cats with concurrent acromegaly. The ripple effect extends to veterinary education, enhancing the knowledge base of practitioners and improving the standard of care across the globe.

Beyond the direct medical impact, The O’Malley Fund serves as a powerful reminder of the human-animal bond and the responsibility pet owners and the veterinary community share in ensuring the well-being of companion animals. By providing a clear avenue for focused research, EveryCat Health Foundation is not only addressing an immediate health crisis but also contributing to a broader understanding of metabolic diseases that can benefit both feline and human populations. The collaborative nature of diabetes research, where findings in one species can inform another, highlights the far-reaching potential of this initiative.

Conclusion: A Call to Action for Feline Health

The launch of The O’Malley Fund for Diabetes and Endocrinopathies on March 2, 2026, marks a pivotal moment for feline health. Inspired by the resilience and love of one extraordinary cat, O’Malley, and championed by Kara Burns, this fund represents a dedicated commitment to tackling one of the most challenging and prevalent diseases affecting our feline companions. EveryCat Health Foundation’s "Springing into Action" campaign, anchored by this vital new fund, is poised to make profound contributions to veterinary science. Pet owners, veterinarians, and animal advocates are encouraged to contribute to The O’Malley Fund to support the critical research needed to improve the lives of diabetic cats worldwide. Make a donation to The O’Malley Fund for Diabetes and Endocrinopathies HERE to become a part of O’Malley’s enduring legacy and help bring hope and healing to countless cats.

References

1. Taylor S Panel Chair, Cannon M, Church D, Fleeman L, Fracassi F, Gilor C, Mott J, Niessen S. iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats. J Feline Med Surg. 2025 Nov;27(11):1-37.
2. Gilor C, Niessen SJ, Furrow E, et al. What’s in a name? Classification of diabetes mellitus in veterinary medicine and why it matters. J Vet Intern Med 2016; 30:927–940.
3. Bugbee AC, Fujishiro MA. Managing Feline Diabetes Mellitus. Today’s Veterinary Practice. May/June 2019. Pp. 55-62.
4. Behrend E, Holford A, Lathan P, Rucinsky R, Schulman R. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. J Am Anim Hosp Assoc. 2018 Jan/Feb;54(1):1-21.